Polymyositis: new light on pathogenesis and treatment.
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001327:Autoimmune Diseases; D003882:Dermatomyositis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009135:Muscular Diseases / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D009975:Orthomyxoviridae; D010849:Picornaviridae; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011241:Prednisone